Interleukin-23 and its correlation with disease activity, joint damage, and functional disability in rheumatoid arthritis

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

The purpose of this study was to compare the serum interleukin (IL)-23 levels between rheumatoid arthritis (RA) patients and healthy controls and to determine the correlation of IL-23 levels with disease activity, joint damage and functional disability in RA. Serum samples were obtained from 45 patients with RA and 45 healthy controls. The enzyme-linked immunosorbent assay method was used for quantitative analysis of IL-23. All the RA patients were assessed for disease activity based on the 28-joint disease activity score, joint damage based on modified Sharp score, and functional ability using the Health Assessment Questionnaire-Disability Index. The mean serum IL-23 level was much higher among the RA patients (24.50 ± 13.98 pg/mL) compared to the controls (5.98 ± 3.40 pg/mL; p < 0.01). There was a significant positive relationship between IL-23 levels and disease activity and questionnaire scores (p = 0.003 and 0.020, respectively). On logistic regression analysis, IL-23 levels were significantly higher in patients with moderate to high disease activity (p = 0.008, odds ratio = 1.073, 95% confidence interval = 1.019-1.130) and patients with significant functional disability (p = 0.008, odds ratio = 1.085, 95% confidence interval = 1.021-1.153). RA patients have significantly higher levels of serum IL-23. The IL-23 levels correlate well with disease activity and functional disability but not with radiographic joint damage.

Original languageEnglish
Pages (from-to)337-342
Number of pages6
JournalKaohsiung Journal of Medical Sciences
Volume30
Issue number7
DOIs
Publication statusPublished - 2014

Fingerprint

Interleukin-23
Joint Diseases
Rheumatoid Arthritis
Serum
Joints
Odds Ratio
Confidence Intervals
Logistic Models
Enzyme-Linked Immunosorbent Assay
Regression Analysis
Health

Keywords

  • Disease activity
  • Interleukin 23
  • Joint damage
  • Rheumatoid arthritis

ASJC Scopus subject areas

  • Medicine(all)

Cite this

@article{01c7c90259c04fa89240260ab04d1066,
title = "Interleukin-23 and its correlation with disease activity, joint damage, and functional disability in rheumatoid arthritis",
abstract = "The purpose of this study was to compare the serum interleukin (IL)-23 levels between rheumatoid arthritis (RA) patients and healthy controls and to determine the correlation of IL-23 levels with disease activity, joint damage and functional disability in RA. Serum samples were obtained from 45 patients with RA and 45 healthy controls. The enzyme-linked immunosorbent assay method was used for quantitative analysis of IL-23. All the RA patients were assessed for disease activity based on the 28-joint disease activity score, joint damage based on modified Sharp score, and functional ability using the Health Assessment Questionnaire-Disability Index. The mean serum IL-23 level was much higher among the RA patients (24.50 ± 13.98 pg/mL) compared to the controls (5.98 ± 3.40 pg/mL; p < 0.01). There was a significant positive relationship between IL-23 levels and disease activity and questionnaire scores (p = 0.003 and 0.020, respectively). On logistic regression analysis, IL-23 levels were significantly higher in patients with moderate to high disease activity (p = 0.008, odds ratio = 1.073, 95{\%} confidence interval = 1.019-1.130) and patients with significant functional disability (p = 0.008, odds ratio = 1.085, 95{\%} confidence interval = 1.021-1.153). RA patients have significantly higher levels of serum IL-23. The IL-23 levels correlate well with disease activity and functional disability but not with radiographic joint damage.",
keywords = "Disease activity, Interleukin 23, Joint damage, Rheumatoid arthritis",
author = "Dalila, {Adnan Siti} and {Mohamed Said}, {Mohd Shahrir} and Shaharir, {Syahrul Sazliyana} and {Abdul Wahab}, Asrul and Low, {Soo Fin} and Shah, {Shamsul Azhar} and Sakthiswary Rajalingham",
year = "2014",
doi = "10.1016/j.kjms.2014.02.010",
language = "English",
volume = "30",
pages = "337--342",
journal = "Kaohsiung Journal of Medical Sciences",
issn = "1607-551X",
publisher = "Elsevier (Singapore) Pte Ltd",
number = "7",

}

TY - JOUR

T1 - Interleukin-23 and its correlation with disease activity, joint damage, and functional disability in rheumatoid arthritis

AU - Dalila, Adnan Siti

AU - Mohamed Said, Mohd Shahrir

AU - Shaharir, Syahrul Sazliyana

AU - Abdul Wahab, Asrul

AU - Low, Soo Fin

AU - Shah, Shamsul Azhar

AU - Rajalingham, Sakthiswary

PY - 2014

Y1 - 2014

N2 - The purpose of this study was to compare the serum interleukin (IL)-23 levels between rheumatoid arthritis (RA) patients and healthy controls and to determine the correlation of IL-23 levels with disease activity, joint damage and functional disability in RA. Serum samples were obtained from 45 patients with RA and 45 healthy controls. The enzyme-linked immunosorbent assay method was used for quantitative analysis of IL-23. All the RA patients were assessed for disease activity based on the 28-joint disease activity score, joint damage based on modified Sharp score, and functional ability using the Health Assessment Questionnaire-Disability Index. The mean serum IL-23 level was much higher among the RA patients (24.50 ± 13.98 pg/mL) compared to the controls (5.98 ± 3.40 pg/mL; p < 0.01). There was a significant positive relationship between IL-23 levels and disease activity and questionnaire scores (p = 0.003 and 0.020, respectively). On logistic regression analysis, IL-23 levels were significantly higher in patients with moderate to high disease activity (p = 0.008, odds ratio = 1.073, 95% confidence interval = 1.019-1.130) and patients with significant functional disability (p = 0.008, odds ratio = 1.085, 95% confidence interval = 1.021-1.153). RA patients have significantly higher levels of serum IL-23. The IL-23 levels correlate well with disease activity and functional disability but not with radiographic joint damage.

AB - The purpose of this study was to compare the serum interleukin (IL)-23 levels between rheumatoid arthritis (RA) patients and healthy controls and to determine the correlation of IL-23 levels with disease activity, joint damage and functional disability in RA. Serum samples were obtained from 45 patients with RA and 45 healthy controls. The enzyme-linked immunosorbent assay method was used for quantitative analysis of IL-23. All the RA patients were assessed for disease activity based on the 28-joint disease activity score, joint damage based on modified Sharp score, and functional ability using the Health Assessment Questionnaire-Disability Index. The mean serum IL-23 level was much higher among the RA patients (24.50 ± 13.98 pg/mL) compared to the controls (5.98 ± 3.40 pg/mL; p < 0.01). There was a significant positive relationship between IL-23 levels and disease activity and questionnaire scores (p = 0.003 and 0.020, respectively). On logistic regression analysis, IL-23 levels were significantly higher in patients with moderate to high disease activity (p = 0.008, odds ratio = 1.073, 95% confidence interval = 1.019-1.130) and patients with significant functional disability (p = 0.008, odds ratio = 1.085, 95% confidence interval = 1.021-1.153). RA patients have significantly higher levels of serum IL-23. The IL-23 levels correlate well with disease activity and functional disability but not with radiographic joint damage.

KW - Disease activity

KW - Interleukin 23

KW - Joint damage

KW - Rheumatoid arthritis

UR - http://www.scopus.com/inward/record.url?scp=84902384533&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84902384533&partnerID=8YFLogxK

U2 - 10.1016/j.kjms.2014.02.010

DO - 10.1016/j.kjms.2014.02.010

M3 - Article

VL - 30

SP - 337

EP - 342

JO - Kaohsiung Journal of Medical Sciences

JF - Kaohsiung Journal of Medical Sciences

SN - 1607-551X

IS - 7

ER -